GlassScriptPhysician profile
Elizabeth Tu
NPI 1023463379
$4,239.34
in general payments reported to CMS, 2019-2025
35 companies · $777 in 2025
The $777 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $141 · 2021: $793 · 2022: $506 · 2023: $1,123 · 2024: $638 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,538.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,114.34 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $482.83 | 2021-2025 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $376.76 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $363.28 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $286.03 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $254.24 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Pfizer INC. | $218.78 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $142.95 | 2022-2023 | Quviviq |
| Baxter Healthcare | $105.00 | 2022 | |
| Optinose US, INC. | $102.06 | 2022 | |
| Exact Sciences Corporation | $92.90 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $80.29 | 2023-2024 | |
| Mayne Pharma Commercial LLC | $58.49 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $50.38 | 2022 | |
| Amgen INC. | $43.00 | 2025 | Tezspire, Repatha, Otezla |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $42.31 | 2024 | (Ck7) Extended Holter |
| Antares Pharma, INC. | $38.79 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Renalytix Ai, INC. | $37.20 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Janssen Pharmaceuticals, INC | $34.97 | 2023 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $32.06 | 2022-2024 | Trintellix |
| Boston Scientific Corporation | $27.48 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Halozyme INC | $23.80 | 2023 | |
| Insmed, INC. | $22.39 | 2025 | Arikayce |
| Genentech USA, INC. | $22.29 | 2021 | |
| Nestle Healthcare Nutrition INC. | $21.68 | 2023 | |
| Electromed, INC. | $19.39 | 2025 | Smartvest |
| Alk-Abello, INC | $18.64 | 2024 | Odactra, Ragwitek, Grastek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.30 | 2019 | |
| Endogastric Solutions, INC | $17.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.96 | 2021 | |
| Organon LLC | $16.63 | 2022 | |
| Dexcom, INC. | $15.00 | 2025 | Dexcom G6 Transmitter |
| Tris Pharma INC | $14.65 | 2025 | Dyanavel Xr |
| Allergan, INC. | $13.99 | 2019 | |
| Astellas Pharma US INC | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Tu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.